DK0653211T3 - Blodkoagulationsnormalisator indeholdende TCF-II som aktiv bestanddel - Google Patents

Blodkoagulationsnormalisator indeholdende TCF-II som aktiv bestanddel

Info

Publication number
DK0653211T3
DK0653211T3 DK93916161T DK93916161T DK0653211T3 DK 0653211 T3 DK0653211 T3 DK 0653211T3 DK 93916161 T DK93916161 T DK 93916161T DK 93916161 T DK93916161 T DK 93916161T DK 0653211 T3 DK0653211 T3 DK 0653211T3
Authority
DK
Denmark
Prior art keywords
blood coagulation
normalizer
active ingredient
containing tcf
tcf
Prior art date
Application number
DK93916161T
Other languages
English (en)
Inventor
Hiroaki Masunaga
Nobuaki Fujise
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of DK0653211T3 publication Critical patent/DK0653211T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
DK93916161T 1992-07-16 1993-07-14 Blodkoagulationsnormalisator indeholdende TCF-II som aktiv bestanddel DK0653211T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21222892 1992-07-16
JP11780993 1993-04-21
PCT/JP1993/000974 WO1994002165A1 (en) 1992-07-16 1993-07-14 Blood coagulation normalizer containing tcf-ii as active ingredient

Publications (1)

Publication Number Publication Date
DK0653211T3 true DK0653211T3 (da) 2002-05-06

Family

ID=26455863

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93916161T DK0653211T3 (da) 1992-07-16 1993-07-14 Blodkoagulationsnormalisator indeholdende TCF-II som aktiv bestanddel

Country Status (11)

Country Link
US (1) US5714461A (da)
EP (1) EP0653211B1 (da)
JP (1) JP3634359B2 (da)
KR (1) KR100260964B1 (da)
AT (1) ATE206929T1 (da)
AU (1) AU674871B2 (da)
CA (1) CA2140010C (da)
DE (1) DE69330960T2 (da)
DK (1) DK0653211T3 (da)
ES (1) ES2165855T3 (da)
WO (1) WO1994002165A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU220167B (hu) * 1994-12-27 2001-11-28 Snow Brand Milk Products Co. Ltd. TCF-mutáns
WO1997012628A1 (en) * 1995-10-05 1997-04-10 Genentech, Inc. Methods and compositions for treating vascular stenosis
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
US20020041863A1 (en) 1997-03-14 2002-04-11 Masamichi Kojiro Preventive and/or therapeutic agent for cachexia
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤
JPH11269091A (ja) * 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び／又は治療剤
WO2005058951A1 (ja) 2003-12-16 2005-06-30 Toshikazu Nakamura 糖鎖欠損型肝細胞増殖因子
US7262637B2 (en) * 2005-03-22 2007-08-28 Micron Technology, Inc. Output buffer and method having a supply voltage insensitive slew rate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076701A (en) * 1975-07-29 1978-02-28 Immunology Research Foundation, Inc. Tumor complement fraction recovery method and product
US4490549A (en) * 1977-04-19 1984-12-25 The Upjohn Company Enlarged-hetero-ring prostacyclin analogs
JPH0296598A (ja) * 1988-10-03 1990-04-09 Sapporo Breweries Ltd リンフォカイン活性化キラー細胞誘導抑制因子ｌａｋｓｆ，その製造法およびそれを有効成分とする免疫抑制剤
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
WO1992001053A1 (fr) * 1990-07-13 1992-01-23 Snow Brand Milk Products Co., Ltd. Plasmide contenant l'adn qui code pour la sequence d'acides amines du facteur tcf-ii, cellules transformees par ce plasmide et production d'une substance physiologiquement active grace a l'utilisation de ce plasmide
JPH0597A (ja) * 1991-06-21 1993-01-08 Snow Brand Milk Prod Co Ltd 新規抗ｔｃｆ−ｉｉモノクローナル抗体及びそれを用いるｔｃｆ−ｉｉの測定方法
DE69334087T2 (de) * 1992-07-16 2007-07-05 Daiichi Pharmaceutical Co., Ltd. Arzneimittelzusammensetzung enthaltend TCF-II
JPH07507328A (ja) * 1992-12-28 1995-08-10 雪印乳業株式会社 Ｔｃｆ変異体
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤

Also Published As

Publication number Publication date
CA2140010C (en) 2008-04-01
DE69330960D1 (de) 2001-11-22
CA2140010A1 (en) 1994-02-03
EP0653211B1 (en) 2001-10-17
AU4583393A (en) 1994-02-14
DE69330960T2 (de) 2002-04-11
EP0653211A4 (en) 1996-06-26
JP3634359B2 (ja) 2005-03-30
KR950702433A (ko) 1995-07-29
AU674871B2 (en) 1997-01-16
ATE206929T1 (de) 2001-11-15
KR100260964B1 (ko) 2000-07-01
US5714461A (en) 1998-02-03
EP0653211A1 (en) 1995-05-17
WO1994002165A1 (en) 1994-02-03
ES2165855T3 (es) 2002-04-01

Similar Documents

Publication Publication Date Title
ATE290867T1 (de) Synthetische katalytische freie radikalfänger, verwendbar als antioxidantien zur prävention und therapie von krankheiten
DE69200675D1 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
ATE136030T1 (de) Azaheterocyclylmethyl-chromane als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
DE3851711D1 (de) Verwendung von Morphinantagonisten zur Herstellung von Medikamenten mit immunmodulatorischer und antiviraler Wirkung, insbesondere bestimmt zur Behandlung von erworbenen Immunmangelzuständen.
DE3683333D1 (de) Mittel zur behandlung von akne vulgaris und deren herstellung.
ATE69548T1 (de) Vitamin e-haltiges mittel zur verbesserung der eigenschaften des blutes.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
DK0653211T3 (da) Blodkoagulationsnormalisator indeholdende TCF-II som aktiv bestanddel
DE3865368D1 (de) Thiophensulfonamide zur behandlung von glaukom.
ES2093357T3 (es) Metodo de tratamiento de la alopecia.
ATE136896T1 (de) Piperidylmethyl substituierte chromanderivate als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
ES2159294T3 (es) Metodo y composicion para el tratamiento de la caida del cabello.
DE68905657T2 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
DE69636814D1 (de) Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
ES2181722T3 (es) Marcfortinas sustituidas en la posicion 14 y derivados utiles como agentes antiparasitarios.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
ATE6124T1 (de) Arzneimittel zur lokalen behandlung des glaukoms.
RU95113977A (ru) Средство для лечения ран
HUT54300A (en) Process for producing medicaments suitable for antiviral treatment
RU95120823A (ru) Способ лечения гипертрофического гингивита
ATE88636T1 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augenhypertension und glaukom.